title: Prenatal amphetamine exposure effects on dopaminergic receptors and transporter in postnatal rats.
abstract: We investigated the influence of prenatal amphetamine exposure (PAE) on dopamine (DA) receptors, and dopamine transporter (DAT) in various striatal and limbic subregions and locomotor activity induced by novel environmental conditions and amphetamine at two postnatal ages, 35 days old (prepubertal) and 60 days old (postpubertal). Experiments were carried out on pregnant female Sprague-Dawley rats, which were daily injected with either d-amphetamine sulfate (1 mg/kg) or saline solution (0.9%) for 11 days, from gestation day 11-21. In PAE rats compared to control we found the following: at pre-pubertal age, an enhancement of DA D1 in the dorsolateral area of the caudate-putamen (CPu), CPu-ventral and shell of the nucleus accumbens (NAcc) with a decrement of the DA D3 receptors in NAcc, olfactory tubercle (OT), and the islands of Calleja (IoC); whereas at postpubertal age, an increase in the levels of DAT in the NAcc and fundus of the CPu, and OT along with a decrease in the expression of DA D2 receptors only in the NAcc shell were found in PAE rats compared to control. In addition, amphetamine induces a marked decrease in locomotor activity at postpubertal age in rats with PAE. These results suggest a differential effect of amphetamines on the DAT mechanism of the nervous system during embryonic development of animals with implications in behavior and drug addictions at adulthood age.
authors: Instituto de Fisiología, Universidad Autónoma de Puebla, 14 Sur 6301, San Manuel, 72570 Puebla, CP, México. gflores@siu.buap.mx
authors: Gonzalo
authors: G
authors: Flores
authors: María
authors: M
authors: de Jesús Gómez-Villalobos
authors: Leonardo
authors: L
authors: Rodríguez-Sosa
references: Synapse. 1994 Jul;17(3):210-5
references: 7974205
references: Pharmacol Ther. 2009 May;122(2):125-39
references: 19268688
references: Acta Paediatr. 1996 Feb;85(2):204-8
references: 8640051
references: Mol Psychiatry. 1998 May;3(3):261-5
references: 9672902
references: Int Rev Neurobiol. 2009;88:25-41
references: 19897073
references: Am J Drug Alcohol Abuse. 2009;35(3):161-77
references: 19462300
references: Science. 2007 Mar 2;315(5816):1267-70
references: 17332411
references: Brain Res Rev. 2008 Aug;58(2):303-13
references: 18433875
references: Nature. 1997 Apr 24;386(6627):830-3
references: 9126741
references: Synapse. 2010 May;64(5):397-402
references: 20034014
references: Synapse. 2002 Nov;46(2):79-82
references: 12211085
references: Neuroscience. 1999;91(2):549-56
references: 10366012
references: Psychiatry Res. 2004 Dec 15;132(2):95-106
references: 15598544
references: Addiction. 2007 Apr;102 Suppl 1:16-32
references: 17493050
references: Neurotoxicol Teratol. 2008 Nov-Dec;30(6):495-502
references: 18558471
references: Pharmacol Biochem Behav. 1993 Feb;44(2):487-9
references: 8095344
references: Biochem Biophys Res Commun. 2007 Jan 19;352(3):823-9
references: 17150178
references: Neuroreport. 2008 Jul 16;19(11):1137-40
references: 18596615
references: Nutrition. 2005 Jun;21(6):775-7
references: 15925305
references: Neurotoxicology. 1993 Spring;14(1):83-144
references: 8361683
references: Eur J Neurosci. 2006 Oct;24(7):2075-83
references: 17067304
references: Dev Neurosci. 2009;31(3):193-201
references: 19145071
references: J Neurosci. 1995 May;15(5 Pt 2):4102-8
references: 7751968
references: Brain Res. 1995 Jul 10;685(1-2):179-86
references: 7583244
references: Arch Dis Child Fetal Neonatal Ed. 2010 Jan;95(1):F36-41
references: 19679891
references: Neurobiol Learn Mem. 2009 Mar;91(3):207-17
references: 19146964
references: Synapse. 2011 Jun;65(6):490-6
references: 20936687
references: J Comp Neurol. 1998 Dec 21;402(3):353-71
references: 9853904
references: Neuroscience. 1995 Apr;65(3):709-30
references: 7609871
references: Nature. 1996 Feb 15;379(6566):606-12
references: 8628395
references: Life Sci. 2010 Mar 27;86(13-14):482-7
references: 20153755
references: Nat Neurosci. 2006 Aug;9(8):1050-6
references: 16829955
references: Nat Neurosci. 2002 Feb;5(2):169-74
references: 11802171
references: Nat Rev Neurosci. 2009 Apr;10(4):303-12
references: 19277053
references: Am J Psychiatry. 1990 Jun;147(6):719-24
references: 2343913
references: Eur J Pharmacol. 1993 Aug 3;239(1-3):183-7
references: 7901028
references: Synapse. 1996 Aug;23(4):335-43
references: 8855519
references: J Neurosci. 2002 Apr 1;22(7):2977-88
references: 11923462
references: J Neurosci. 1995 Jul;15(7 Pt 2):5222-37
references: 7623147
references: Neuropharmacology. 2004;47 Suppl 1:33-46
references: 15464124
references: Brain Res Rev. 2007 Nov;56(1):27-78
references: 17574681
references: Ann N Y Acad Sci. 2010 Feb;1187:316-40
references: 20201860
references: J Neurosci. 1996 Mar 15;16(6):2020-6
references: 8604046
references: Handb Exp Pharmacol. 2006;(175):215-32
references: 16722238
references: Cult Med Psychiatry. 2011 Mar;35(1):90-7
references: 21190069
references: J Neurosci. 1995 Mar;15(3 Pt 1):1714-23
references: 7534339
references: J Neurosci. 1994 Jan;14(1):88-106
references: 7904306
references: Prog Neurobiol. 2005 Apr;75(6):406-33
references: 15955613
references: Neuropharmacology. 1993 Jul;32(7):721-3
references: 8361584
references: Ann N Y Acad Sci. 1998 May 30;844:293-302
references: 9668686
references: Neurotoxicol Teratol. 2006 Mar-Apr;28(2):173-80
references: 16529908
references: Acta Paediatr. 2000 Dec;89(12):1474-8
references: 11195239
references: Synapse. 1993 Jun;14(2):169-77
references: 8101394
references: Trends Pharmacol Sci. 1998 Jul;19(7):248-51
references: 9703753
references: Arch Gen Psychiatry. 2006 Sep;63(9):999-1008
references: 16953002
references: Acta Paediatr Suppl. 1994 Nov;404:27-31
references: 7531039